Literature DB >> 12845680

Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.

Véronique Dalstein1, Didier Riethmuller, Jean-Luc Prétet, Karine Le Bail Carval, Jean-Loup Sautière, Jean-Pierre Carbillet, Bernadette Kantelip, Jean-Patrick Schaal, Christiane Mougin.   

Abstract

Oncogenic HPV types are the major cause of worldwide cervical cancer, but only a small proportion of infected women will develop high-grade cervical intraepithelial neoplasia or cancer (CIN2/3+). We performed a prospective study including 781 women with normal, atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LGSIL) cytology, and infected or not by high-risk (HR) HPV tested by Hybrid Capture II. Women were followed up every 6 months for a median period of 22 months. Among the HR-HPV-positive women at entry, more than half cleared their virus in 7.5 months; the clearance rate was greater for low viral loads than for high loads and also was higher in women with an initial ASCUS/LGSIL smear than in women with normal cytology. The incidence of cytologic abnormalities strongly depended on baseline viral load and HR-HPV persistence. Maintenance of cytologic abnormalities was associated with the outcome of HR-HPV status (negative<transient<persistent) but not with baseline load. Progression to CIN2/3+ was achieved only in women with persistent HR-HPV infection. The risk of CIN2/3+ also was increased with initial high loads (> or =100 pg/mL). Conversely, women who were consistently HR-HPV negative or transiently HR-HPV positive, whatever the cytology at baseline was, did not develop CIN2/3+ during follow-up. Age seemed to affect only the rate of incident HR-HPV infection. In conclusion, our data suggest that women repeatedly tested positive for HR-HPV are at risk of developing CIN2/3+, even when initial cytology is normal. A high viral load could be used as a short-term marker of progression toward precancerous lesions, although lower load does not inevitably exclude progressive disease. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12845680     DOI: 10.1002/ijc.11222

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  111 in total

1.  HPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infections.

Authors:  Anna Manawapat-Klopfer; Lisa Wang; Juliane Haedicke-Jarboui; Frank Stubenrauch; Christian Munk; Louise T Thomsen; Peter Martus; Susanne K Kjaer; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

2.  p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri.

Authors:  Giovanni Negri; Fabio Vittadello; Fabio Romano; Armin Kasal; Francesco Rivasi; Salvatore Girlando; Christine Mian; Eduard Egarter-Vigl
Journal:  Virchows Arch       Date:  2004-10-09       Impact factor: 4.064

3.  Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program.

Authors:  A T Hesselink; N W J Bulkmans; J Berkhof; A T Lorincz; C J L M Meijer; P J F Snijders
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

4.  Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems.

Authors:  Christopher Payan; Alexandra Ducancelle; Mohamed H Aboubaker; Julien Caer; Malena Tapia; Amelie Chauvin; Damien Peyronnet; Elodie Le Hen; Zohra Arab; Marie-Christine Legrand; Adissa Tran; Edith Postec; Françoise Tourmen; Martine Avenel; Chantal Malbois; Marie-Anne De Brux; Philippe Descamps; Francoise Lunel
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

5.  Viral DNA load of high-risk human papilloma virus is closely associated with the grade of cervical lesions.

Authors:  Guqun Shen; Jingxin Cheng; Yan Wang; Ping Zhou; Guoqing Zhang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

6.  Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3.

Authors:  Long Fu Xi; Laura A Koutsky; Philip E Castle; Cosette M Wheeler; Denise A Galloway; Constance Mao; Jesse Ho; Nancy B Kiviat
Journal:  J Natl Cancer Inst       Date:  2009-01-27       Impact factor: 13.506

7.  High grade cervical intraepithelial neoplasia and viral load of high-risk human papillomavirus: significant correlations in patients of 22 years old or younger.

Authors:  Yuanchun Xu; Jorge Dotto; Yiang Hui; Kara Lawton; Kevin Schofield; Pei Hui
Journal:  Int J Clin Exp Pathol       Date:  2008-07-25

8.  Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development.

Authors:  Rachel L Winer; Tiffany G Harris; Long Fu Xi; Kathrin U Jansen; James P Hughes; Qinghua Feng; Carolee Welebob; Jesse Ho; Shu-Kuang Lee; Joseph J Carter; Denise A Galloway; Nancy B Kiviat; Laura A Koutsky
Journal:  J Med Virol       Date:  2009-04       Impact factor: 2.327

9.  Six-year regression and progression of cervical lesions of different human papillomavirus viral loads in varied histological diagnoses.

Authors:  Shao-Ming Wang; Danny Colombara; Ju-Fang Shi; Fang-Hui Zhao; Jing Li; Feng Chen; Wen Chen; Shu-Min Li; Xun Zhang; Qin-Jing Pan; Jerome L Belinson; Jennifer S Smith; You-Lin Qiao
Journal:  Int J Gynecol Cancer       Date:  2013-05       Impact factor: 3.437

10.  Should we target patients with autoimmune diseases for human papillomavirus vaccine uptake?

Authors:  Candace H Feldman; Seoyoung C Kim
Journal:  Expert Rev Vaccines       Date:  2014-06-17       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.